Projected Growth of the Global Contraceptives Market to Reach $40 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptives market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Contraceptives Market By The End Of 2029?

The contraceptives market has demonstrated substantial growth in recent years. It is projected to expand from $27.92 billion in 2024 to $29.74 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%. Historically, this growth can be ascribed to several factors, including the introduction of the birth control pill, enhanced awareness and education surrounding contraception, legal and social advancements that promote reproductive rights, global efforts in population control, and a surge in the utilization of generic and low-cost drugs and devices.

The contraceptives market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach “$40 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecast period stems from factors such as an increasing emphasis on male contraceptives, enhanced availability of contraception in developing nations, the incorporation of digital health technologies in contraception, a heightened need for long-acting reversible contraceptives (LARCS), and easier accessibility to over-the-counter drugs on the online platform. Key trends for the forecast period encompass technological advancements in contraceptive methods, a move towards non-hormonal and natural contraceptive methods, broadened over-the-counter access to certain contraceptives, a focus on user-friendly and discreet contraceptive options, and the integration of telemedicine in contraceptive counseling and prescriptions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which Business Drivers Are Underpinning The Growth Of The Contraceptives Market?

The increasing incidence of sexually transmitted illnesses or diseases is fueling the demand for contraceptives. Sexually transmitted diseases (STDs) are infections transmitted from one individual to another through sexual interaction. The most common forms of contact involve anal, oral, and vaginal intercourse, though they can also spread via other close physical contact methods. Contraceptives are utilized to manage the transmission of sexually transmitted diseases like herpes and HPV, which primarily spread through skin-to-skin contact. For instance, in May 2023, according to the Minnesota Department of Health, a US-based state health agency of the State of Minnesota, primary and secondary syphilis cases rose by 19% in 2022, from 564 in 2021 to 676 in 2022. In 2022, 20 instances of congenital syphilis in babies were recorded, which represents a 42 % increase from 2021, when 14 cases of congenital syphilis were documented. Therefore, the increase in sexually transmitted illnesses or diseases is projected to boost the demand for contraceptives during the forecast period.

What Are The Principal Segment Types In The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

How Are Industry Trends Steering The Expansion Of The Contraceptives Market?

Leading companies in the contraceptives market are concentrating on developing innovative contraceptive solutions, including the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives, to enhance user convenience, increase effectiveness, and provide long-term birth control options. These advancements aim to reduce the need for frequent dosing, improve accessibility, and minimize side effects, thereby offering more reliable and discreet contraceptive solutions for individuals seeking better reproductive health management. For instance, in October 2023, the Health and Family Welfare Ministry, an India-based government agency, introduced two new methods, the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, with the goal of improving family planning services. These methods are part of the National Family Planning Programme and are designed to enhance maternal and infant health outcomes. The introduction of these contraceptives seeks to decrease maternal and infant morbidity and mortality rates by providing a wider range of options for family planning. This initiative reflects a broader strategy to bolster reproductive health services in Karnataka, ensuring that women have access to safe and effective contraceptive methods.

Which Companies Are Contributing Significantly To The Contraceptives Market Growth?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Offers The Most Opportunity For Contraceptives Market Expansion?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795